The FDA approves the first infectious treatment for the most common type of lung cancer
For immediate release: 18 December 2020 Today, the U.S. Food and Drug Administration approved Tagrisso (osimertinib) as the first diagnostic treatment for patients with non-small cell lung cancer, …
